Disclaimer: Past performance is not an indicator of future performance and current or future trends. The indications could be based on figures denominated in a currency that may be different from the currency of your residence country and therefore the return may increase or decrease as a result of currency fluctuations. Capital at risk: all financial investments involve an element of risk. Therefore, the value of the investment and the income from it will vary and the initial investment amount cannot be guaranteed. Any reference to a security is not a recommendation to buy or sell that security.
Lower-than-expected EU CPI fuels speculation of interest rate cuts next year.
The Disruptive Strategist: The rise of GLP-1 weight loss drugs
30 November 2023
GLP-1 weight loss drugs are transforming the healthcare scene. Some analysts are predicting that the anti-obesity market may become the largest pharmaceutical market in history, while on the other hand, share prices of medical device companies, particularly those specialising in diabetes and obesity management, are beginning to feel the pressure.
Charles Hepworth Blog
US Q3 GDP revised up to 5.2%
29 November 2023
Higher business investment and government spending lift growth to a level likely to worry policymakers, albeit consensus still says rates have peaked.